Manool, a Salvia officinalis diterpene, induces selective cytotoxicity in cancer cells

Pollyanna Francielli de Oliveira1, Carla Carolina Munari1, Heloiza Diniz Nicolella1

  • 1Universidade de Franca, Avenida Dr. Armando Salles de Oliveira, 201 - Parque Universitário, Franca, São Paulo, 14404-600, Brazil.

Cytotechnology
|November 9, 2015
PubMed

Insights

Manool, a natural compound from Salvia officinalis, shows potent anticancer activity against various cancer cell lines, including HeLa and U343. It demonstrates high selectivity, targeting tumor cells while sparing normal cells, suggesting therapeutic potential.

Area of Science:

  • Pharmacology
  • Natural Products Chemistry
  • Oncology

Background:

  • Salvia officinalis (common sage) is a plant with a long history of medicinal use.
  • Diterpenes are a class of naturally occurring compounds with diverse biological activities.
  • Cancer remains a major global health challenge, necessitating the search for novel therapeutic agents.

Purpose of the Study:

  • To evaluate the cytotoxic and selective activity of manool, a diterpene from Salvia officinalis, against a panel of human and murine cancer cell lines.
  • To compare the efficacy of manool against cancer cells versus normal cells to assess its therapeutic potential.

Main Methods:

  • Manool was isolated from Salvia officinalis.
  • Cytotoxicity was assessed using the XTT colorimetric assay.
  • The study included human cancer cell lines (HeLa, HepG2, MCF-7, U343, U251, MO59J) and murine melanoma cells (B16F10).
  • A normal Chinese hamster lung fibroblast cell line (V79) was used for selectivity comparison.

Main Results:

  • Manool exhibited significant cytotoxic activity against HeLa (IC50 = 6.7 ± 1.1 µg/mL) and U343 (IC50 = 6.7 ± 1.2 µg/mL) cancer cell lines.
  • Manool demonstrated higher cytotoxicity towards tested tumor cell lines compared to the normal V79 cell line (IC50 = 49.3 ± 3.3 µg/mL).
  • The compound displayed high selectivity, indicating a favorable therapeutic window.

Conclusions:

  • Manool possesses significant anticancer properties, particularly against cervical adenocarcinoma (HeLa) and glioblastoma (U343) cells.
  • The observed high selectivity of manool suggests its potential as a cancer therapeutic agent with reduced toxicity to normal tissues.
  • Further research into manool's mechanism of action and in vivo efficacy is warranted.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.8K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.2K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.3K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
8.3K